Blog | HemaCare

Tumor-Adjacent Dendritic Cells Crucial for Cancer Growth in T-Cell Leukemia

Jul 13, 2016 1:00:11 PM / by Steffen Porwollik posted in leukemia, stromal cells, T Cells, T lymphocytes, Tumors, white blood cells, Basic Research

0 Comments

Scientists examine the effect of the tumor microenvironment on cancer fate in acute lymphocytic leukemia (ALL), a disease prevalent in young children. They find that the tumor-adjacent dendritic cells provide essential cues for cancer growth.

For the past fifty years, the incidence of acute lymphocytic leukemia (ALL), a cancer of immature white blood cells, has been rising steadily. Currently, about 6,500 new cases occur annually in the US. The onset of the wretched disease is most common in early childhood, between ages 2 and 5, but can also happen later in life. Luckily, modern chemotherapy and stem cell approaches have resulted in a substantial increase in the 5-year survival rate for children affected by the disease, to over 75%. However, outlook remains poor for those that do not respond well to these therapies. As is the case for the disease’s chronic counterpart, CLL, more treatment options are sorely needed (as we recently reported).

Read More

Epigenetic Therapy May be a Boon for Aggressive Leukemia

Aug 24, 2015 1:00:27 PM / by Shweta posted in Cancer, clinical trials, leukemia, T lymphocytes, white blood cells, Basic Research, Immunotherapy (Immunology)

0 Comments

New discovery can make an existing leukemia treatment more effective

Prolymphocytic leukemia (PLL) is a rare and aggressive form of malignancy characterized by marked lymphocytosis and splenomegaly. PLL represents only 2% of all chronic lymphoid leukemias in adults over the age of 30. Most patients with PLL shows involvement of the peripheral blood, bone marrow, lymph nodes, liver, and spleen. In addition, skin infiltration and serious effusions may also occur at rates of approximately 25 and 15 percent, respectively.

Read More

Stem Cell Test to Determine Cytokine Release Syndrome Ahead of Time

Jun 22, 2015 1:00:31 PM / by Shweta posted in drug screening, PBMCs, Stem Cells, T lymphocytes, white blood cells, Whole Blood, Basic Research

0 Comments

Another potential application of human stem cells is to recognize side effects of drugs

Biological therapy is a form of treatment that uses biological materials such as antibodies and stem cells. Several biological therapies, including monoclonal antibodies, are now well established as part of the treatment for many diseases such as cancer, transplant rejection, autoimmune disorders, and infections. Personalized medicine is now a key emerging technology in drug development. However, they can cause adverse side effects in humans. Therefore, biologic therapies require the use of human tissue-based bioassays to measures the efficacy and safety of the drug.

Read More

Skin Cells to Stem Cells: The New Face of Cellular Therapy

Nov 5, 2014 1:00:33 PM / by James Sanchez posted in iPSCs, Sox2, Stem Cells, white blood cells, Basic Research

0 Comments

Scientists have discovered a way to convert human skin cells into transplantable white blood cells via stem cells.

Read More

Science Beneath the Successful Cord Blood Banking

Aug 27, 2014 12:11:33 PM / by Shweta posted in Hematopoietic History, Cord Blood, Stem Cells, white blood cells, Basic Research

0 Comments

Safe cord blood banking: A stock for baby’s long term health

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts